corpus.blog
56,966 blogs · 4,417,066 posts Claim your blog
Record · corpus.blog/posts/01a0874b-b80f-722a-981b-70cd3fcb427e

Footnotes to 2.5 years

blog.jacobtrefethen.com · published 6 September 2026

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at blog.jacobtrefethen.com Wayback capture
0blogs citing
First cited
—
Most recent
—
Rank this month
not ranked
Links from this post
48
Words captured
3,045

Cited by

No blog we hold has cited this post yet.

Links from this post

Link
Host
https://blog.jacobtrefethen.com/footnotes-to-10-tech/
blog.jacobtrefethen.com
Halfway to 5 years Read at the source ↗
blog.jacobtrefethen.com
https://www.nibib.nih.gov/news-events/newsroom/nih-collaborates-diagnostics-manufacturers-obtaining-authorization-multiplex-tests?ref=blog.jacobtrefethen.com
nibib.nih.gov
https://flowflexcovid.com/announcing-the-availability-of-the-new-flowflex-4-in-1-home-test-to-detect-rsv-flua-b-and-covid-for-ages-6-months-and-up/?ref=blog.jacobtrefethen.com
flowflexcovid.com
https://visby.com/products/visby-womens-at-home-sti-test-kit?ref=blog.jacobtrefethen.com
visby.com
https://www.ptaheute.de/serien/selbsttests/so-funktionieren-vierfachtests-bei-atemwegserkrankungen?ref=blog.jacobtrefethen.com
ptaheute.de
https://touchaustralia.com.au/pages/ifu-covid-flu-rsv?ref=blog.jacobtrefethen.com
touchaustralia.com.au
https://www.bmj.com/content/393/bmj-2025-085716?ref=blog.jacobtrefethen.com
bmj.com
https://www.seruminstitute.com/gates-medical-research-institute-and-the-serum-institute-of-india-reach-agreement.php?ref=blog.jacobtrefethen.com
seruminstitute.com
https://www.propublica.org/article/how-big-pharma-company-stalled-tuberculosis-vaccine-to-pursue-bigger-profits?ref=blog.jacobtrefethen.com
propublica.org
https://www.iavi.org/press-release/iavi-and-biofabri-zendal-announce-first-vaccinations-in-the-imagine-clinical-trial-a-large-scale-safety-and-efficacy-trial-of-the-tuberculosis-vaccine-candidate-mtbvac/?ref=blog.jacobtrefethen.com
iavi.org
https://firstwordpharma.com/story/6917867?ref=blog.jacobtrefethen.com
firstwordpharma.com
https://coefficientgiving.org/research/announcing-the-strep-a-vaccine-fund/?ref=blog.jacobtrefethen.com
coefficientgiving.org
https://investors.vaxcyte.com/news-releases/news-release-details/vaxcyte-doses-first-participant-phase-1-study-evaluating-vax-a1?ref=blog.jacobtrefethen.com
investors.vaxcyte.com
https://www.niaid.nih.gov/news-events/experimental-nih-malaria-monoclonal-antibody-protective-malian-children?ref=blog.jacobtrefethen.com
niaid.nih.gov
https://research.lstmed.ac.uk/en/publications/safety-and-efficacy-of-the-monoclonal-antibody-l9ls-for-malaria-p/?ref=blog.jacobtrefethen.com
research.lstmed.ac.uk
https://ctr.pharmacyboardkenya.org/applications/view/1458?ref=blog.jacobtrefethen.com
ctr.pharmacyboardkenya.org
https://www.nature.com/articles/s41591-025-03739-y?ref=blog.jacobtrefethen.com
nature.com
https://pubmed.ncbi.nlm.nih.gov/41005346/?ref=blog.jacobtrefethen.com
pubmed.ncbi.nlm.nih.gov
https://www.science.org/content/article/after-humiliating-raid-burkina-faso-halts-gene-drive-project-fight-malaria?ref=blog.jacobtrefethen.com
science.org
https://www.nature.com/articles/s41586-025-09685-6?ref=blog.jacobtrefethen.com
nature.com
https://genedrivenetwork.org/blog/exploring-the-ecology-of-malaria-mosquitoes-in-sao-tome-and-principe/?ref=blog.jacobtrefethen.com
genedrivenetwork.org
https://genedrivenetwork.org/blog/ucmi-partners-with-equatorial-guinea-to-advance-the-fight-against-malaria/?ref=blog.jacobtrefethen.com
genedrivenetwork.org
https://www.nature.com/articles/s41467-026-75744-9?ref=blog.jacobtrefethen.com
nature.com
https://oxfordbrc.nihr.ac.uk/recruitment-under-way-in-ground-breaking-hepatitis-c-study/?ref=blog.jacobtrefethen.com
oxfordbrc.nihr.ac.uk
https://www.statnews.com/2022/09/14/a-challenge-trial-can-streamline-testing-of-hepatitis-c-vaccines/?ref=blog.jacobtrefethen.com
statnews.com
https://www.science.org/content/article/serious-side-effects-dim-hopes-first-chikungunya-vaccine?ref=blog.jacobtrefethen.com
science.org
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2825%2901862-8/abstract?ref=blog.jacobtrefethen.com
thelancet.com
https://isc.hub.heart.org/daily-coverage/article/22960319/latebreaking-science-reports-on-potential-cerebroprotective-interventions-and-more?ref=blog.jacobtrefethen.com
isc.hub.heart.org
https://www.ahajournals.org/doi/10.1161/STR.0000000000000513?ref=blog.jacobtrefethen.com
ahajournals.org
https://pmc.ncbi.nlm.nih.gov/articles/PMC9699048/?ref=blog.jacobtrefethen.com
pmc.ncbi.nlm.nih.gov
https://www.nejm.org/doi/full/10.1056/NEJMoa2515131?ref=blog.jacobtrefethen.com
nejm.org
https://www.gsk.com/en-gb/media/press-releases/hibsago-bepirovirsen-approved-in-japan-as-first-and-only-functional-cure-for-chronic-hepatitis-b/?utm_source=chatgpt.com
gsk.com
https://investor.precisionbiosciences.com/news-releases/news-release-details/precision-biosciences-announces-new-and-late-breaking-pbgene-hbv?ref=blog.jacobtrefethen.com
investor.precisionbiosciences.com
https://tunetx.com/tune-therapeutics-presents-positive-phase-1b-2a-proof-of-concept-data-on-tune-401-a-first-in-class-epigenetic-silencer-for-patients-with-hepatitis-b-at-easl-2026/?ref=blog.jacobtrefethen.com
tunetx.com
https://openaifoundation.org/careers/program-officer-high-burden-diseases-8dbddc2c-273b-443f-bb66-4598708fc57d?ref=blog.jacobtrefethen.com
openaifoundation.org
https://openaifoundation.org/careers/program-director-high-burden-diseases-339e4bd7-f237-469b-a031-86177ded7d4b?ref=blog.jacobtrefethen.com
openaifoundation.org
https://openaifoundation.org/careers?ref=blog.jacobtrefethen.com
openaifoundation.org
Built to benefit everyone Read at the source ↗
openai.com
https://academic.oup.com/ajrccm/article/211/Supplement_1/A4987/8336561?ref=blog.jacobtrefethen.com
academic.oup.com
https://padinitiative.com/awarded-grants/4j-therapeutics-jeffrey-glenn/?ref=blog.jacobtrefethen.com
padinitiative.com
https://eradivir.com/?ref=blog.jacobtrefethen.com
eradivir.com
https://newsroom.uw.edu/news-releases/a-wrap-for-biologys-greasiest-problem/?ref=blog.jacobtrefethen.com
newsroom.uw.edu
https://harddrugs.worksinprogress.co/episodes/lenacapavir-the-miracle-drug-that-could-end-aids?ref=blog.jacobtrefethen.com
harddrugs.worksinprogress.co
https://www.evidenceaction.org/insights/beat-congenital-syphilis?ref=blog.jacobtrefethen.com
evidenceaction.org
The third wave of American philanthropy Read at the source ↗
nanransohoff.substack.com
https://drive.google.com/file/d/1r1uHbt-RPPMcpTxVv23fgi0kLcCrNQk4/view?usp=drive_link&ref=blog.jacobtrefethen.com
drive.google.com
https://drive.google.com/file/d/1mOF3YO319G7kx7fMUb3t3oYmYtH494No/view?ref=blog.jacobtrefethen.com
drive.google.com